Entrada Therapeutics, Inc (TRDA) insider trading
Every open-market stock purchase and sale by Entrada Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Mpm Bioventures 2018 L.p. (Insider) and 3 others sold $9.1M in the last 90 days.
- Last insider buy: Bernhardt G Zeiher (Director), $29.3K, 5 months ago.
Last 12 months: insiders bought $1.6M (3 buys) and sold $13.9M (19 sales). Last close $4.73 on Oct 22, 2026.
Recent TRDA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 9, 2026 | MPM BioVentures 2014 L.P. (Insider) | Sold | $206K |
| Sep 9, 2026 | Mpm Bioventures 2018 L.p. (Insider) | Sold | $206K |
| Sep 8, 2026 | Mpm Bioventures 2018 L.p. (Insider) | Sold | $1.4M |
| Sep 8, 2026 | MPM BioVentures 2014 L.P. (Insider) | Sold | $1.4M |
| Sep 4, 2026 | Mpm Bioventures 2018 L.p. (Insider) | Sold | $274K |
| Sep 4, 2026 | MPM BioVentures 2014 L.P. (Insider) | Sold | $274K |
| Sep 3, 2026 | Mpm Bioventures 2018 L.p. (Insider) | Sold | $231K |
| Sep 3, 2026 | MPM BioVentures 2014 L.P. (Insider) | Sold | $231K |
| Sep 2, 2026 | Mpm Bioventures 2018 L.p. (Insider) | Sold | $181K |
| Sep 2, 2026 | MPM BioVentures 2014 L.P. (Insider) | Sold | $181K |
| Sep 2, 2026 | Dipal Doshi (CEO) | Sold (not open market) | $62.3K |
| Sep 2, 2026 | Nathan J Dowden (COO) | Sold (not open market) | $18.1K |
| Sep 2, 2026 | Natarajan Sethuraman (President) | Sold (not open market) | $14.9K |
| Sep 2, 2026 | Kory James Wentworth (CFO) | Sold (not open market) | $12.4K |
| Sep 1, 2026 | Mpm Bioventures 2018 L.p. (Insider) | Sold | $205K |
| Sep 1, 2026 | MPM BioVentures 2014 L.P. (Insider) | Sold | $205K |
| Aug 26, 2026 | MPM BioVentures 2014 L.P. (Insider) | Sold | $103K |
| Aug 26, 2026 | Mpm Bioventures 2018 L.p. (Insider) | Sold | $103K |
| Aug 25, 2026 | MPM BioVentures 2014 L.P. (Insider) | Sold | $200K |
| Aug 25, 2026 | Mpm Bioventures 2018 L.p. (Insider) | Sold | $200K |
| Aug 24, 2026 | MPM BioVentures 2014 L.P. (Insider) | Sold | $159K |
| Aug 24, 2026 | Mpm Bioventures 2018 L.p. (Insider) | Sold | $159K |
| Aug 10, 2026 | Kush Parmar (Insider) | Sold | $647K |
| Aug 7, 2026 | Kush Parmar (Insider) | Sold | $358K |
| Aug 7, 2026 | 5AM Ventures V L.P. (Insider) | Sold | $358K |
Who's trading TRDA
- MPM BioVentures 2014 L.P., Insider: sold $3M (9 sales), last Sep 9, 2026
- Mpm Bioventures 2018 L.p., Insider: sold $3M (9 sales), last Sep 9, 2026
- Natarajan Sethuraman, President: sold $399K (1 sale), last Sep 2, 2026
- Nathan J Dowden, COO: sold $426K (3 sales), last Sep 2, 2026
- Dipal Doshi, CEO: other filings, last Sep 2, 2026
- Kory James Wentworth, CFO: sold $434K (5 sales), last Sep 2, 2026
- Kush Parmar, Insider: sold $3.6M (6 sales), last Aug 10, 2026
- 5AM Ventures V L.P., Insider: sold $3M (5 sales), last Aug 7, 2026
- Peter S Kim, Director: other filings, last Jun 10, 2026
- Maha Radhakrishnan, Director: other filings, last Jun 10, 2026
- Gina Chapman, Director: other filings, last Jun 10, 2026
- Mary Thistle, Director: other filings, last Jun 10, 2026
- Bernhardt G Zeiher, Director: bought $29.3K (1 buy), last Jun 10, 2026
- Baker Bros. Advisors LP, Insider: bought $1.6M (16 buys), last Nov 20, 2025
Get free alerts when an insider at Entrada Therapeutics, Inc files a new trade →